Relevance of cyclin D1 and other molecular markers to cancer chemoprevention

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 23-28

  Weinstein, I Bernard ^a  

^a Columbia University ^*  (United States)

Author keywords

cancer; cell cycle; chemoprevention cyclins; markers; prevention

Indexed keywords

CYCLIN D1; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CYCLINE; ONCOPROTEIN; TUMOR MARKER;

CANCER PREVENTION; CANCER RISK; CELL INTERACTION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; CELL CYCLE; GENETICS; NEOPLASM; RISK FACTOR;

ANTICARCINOGENIC AGENTS; CELL CYCLE; CYCLIN D1; CYCLINS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030337951     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4644(1996)25+<23::aid-jcb3>3.0.co;2-4     Document Type: Review

References (19)

1. Weinstein IB (1991): Cancer prevention: Recent progress and future opportunities. Cancer Res 51: 5080S-5085S.
2. Weinstein IB, Santella RM, Perera FP (1995): Molecular Biology and Molecular Epidemiology of Cancer. In Greenwald P, Kramer BS, Weed DL (eds): "Cancer Prevention and Control." New York: Marcell Dekker, Inc , pp 83-110.
3. Weinstein IB, Carothers AM, Santella RM, Perera FP (1995): Molecular mechanisms of mutagenesis and multistage carcinogenesis. In Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds): "The Molecular Basis of Cancer." Philadelphia: WB Saunders, pp 59-85.
4. Hunter T (1991): Cooperation between oncogenes. Cell 64:249-270.
5. Hinds PW, Weinberg RA (1994): Tumor suppressor genes. Curr Opin Genet Dev 4:135-141.
6. Hunter T, Pines J (1994): Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582.
7. Jiang W, Zhang Y-J, Kahn S, Hollstein M, Santella R, Lu S-H, Harris C, Montesano R, Weinstein IB (1993): Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A 90:9026-9030.
8. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994): Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817.
9. Bartkova J, Lukas J, Strauss M, Bartek J (1994): The PRAD-1/cyclin D1 oncogens product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 58:568-573.
10. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR (1996): Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110:669-676.
11. Jiang W, Kahn SM, Zhou P, Zhang Y-J, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB (1991): Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457.
12. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA (1994): Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 91:709-713.
13. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras (1994b): Link between cell cycle control and malignant transformation. Oncogene 9:323-326.
14. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994): Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
15. Lovec H, Grzeschiczek A, Kowalski MB, Moroy T (1994a): Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487-3495.
16. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM (1994): Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124-2130.
17. Zhou P, Jiang W, Zhang Y-J, Kahn SM, Schieren I, Santella RM, Weinstein IB (1995): Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11:571-580.
18. Zhou P, Jiang W, Weghorst CM, Weinstein IB (1996): Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36-39.
19. Arber N, Lightdale C, Rotterdam H, Finegold J, Ahsan H, Han EK-H, Sgambato A, Stevens PD, Green PHR, Neugut AI, Weinstein IB (1996): Increased expression of the cyclin D1 gene in Barrett's Esophagus. Can Epidemiol Biomarkers Prev. 3:457-459.